---
title: 'Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations'
date: '2023-08-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37543237/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230806180720&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Hematopoietic stem cells (HSCs) are the most primitive cell type in the
  hematopoietic hierarchy, which are responsible for sustaining the lifelong production
  of mature blood and immune cells. Due to their superior long-term regenerative capacity,
  HSC therapies such as stem cell transplantation have been used in a broad range
  of hematological disorders. However, the rarity of this population in vivo considerably
  limits its clinical applications and large-scale analyses such as screening ...
disable_comments: true
---
Hematopoietic stem cells (HSCs) are the most primitive cell type in the hematopoietic hierarchy, which are responsible for sustaining the lifelong production of mature blood and immune cells. Due to their superior long-term regenerative capacity, HSC therapies such as stem cell transplantation have been used in a broad range of hematological disorders. However, the rarity of this population in vivo considerably limits its clinical applications and large-scale analyses such as screening ...